TP53 and neoplasm: As p53 mutations are described to occur prior to the onset of neoplasia in patients with chronic ulcerative colitis [30], we investigated expression of mutant p53 in non-dysplastic mucosa from patients in this cohort who progressed to neoplasia compared to those who never progressed using the same tissues that were utilized to assess miRNA expression.